Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-24

Clinical Trial Update: Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the efficacy and safety of adipose-derived mesenchymal stromal cells (AD-MSCs) plus calipcitriol ointment in moderate to sev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AD-MSCs plus Calpocitriol ointment (adipose-derived mesenchymal stromal cells)

Snippet

Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine | Conditions: Mesenchymal Stromal Cells, Psoriasis | Phase 1, Phase 2 | Status: COMPLETED